← Browse by Condition
Medical Condition

eczema atopic

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07441395 Phase 2
Recruiting

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Enrollment
200 pts
Location
United States
Sponsor
Corvus Pharmaceuticals, Inc.
View Trial →